Literature DB >> 21177844

Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias.

M Okamoto1, T Hoshino, Y Kitasato, Y Sakazaki, T Kawayama, K Fujimoto, K Ohshima, H Shiraishi, M Uchida, J Ono, S Ohta, S Kato, K Izuhara, H Aizawa.   

Abstract

Idiopathic interstitial pneumonias (IIPs) are histopathologically classified into several types, including usual interstitial pneumonia (UIP), nonspecific interstitial pneumonia (NSIP) and cryptogenic organising pneumonia (COP). We investigated whether periostin, a matrix protein, could be used as a biomarker to assess histopathological types of IIPs. We performed immunohistochemical analyses in each histopathological type of IIP, examined serum levels of periostin in IIP patients and analysed the relationship between serum levels of periostin and the pulmonary functions in patients with idiopathic pulmonary fibrosis (IPF). Periostin was strongly expressed in lungs of UIP and fibrotic NSIP patients, whereas expression of periostin was weak in the lungs of cellular NSIP and COP patients, as well as in normal lungs. Serum levels of periostin in IPF were significantly higher than those of healthy subjects and COP patients. Furthermore, periostin levels in IPF patients were inversely correlated with their pulmonary functions. Thus, we have found that periostin is a novel component of fibrosis in IIP. Periostin may be a potential biomarker to distinguish IIP with fibrosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21177844     DOI: 10.1183/09031936.00059810

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  70 in total

Review 1.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

Review 2.  Periostin function in communication with extracellular matrices.

Authors:  Akira Kudo; Isao Kii
Journal:  J Cell Commun Signal       Date:  2017-10-30       Impact factor: 5.782

Review 3.  Paracrine functions of fibrocytes to promote lung fibrosis.

Authors:  Kathryn R Kleaveland; Bethany B Moore; Kevin K Kim
Journal:  Expert Rev Respir Med       Date:  2014-01-22       Impact factor: 3.772

Review 4.  Peripheral blood biomarkers in idiopathic pulmonary fibrosis.

Authors:  Rekha Vij; Imre Noth
Journal:  Transl Res       Date:  2012-02-02       Impact factor: 7.012

5.  Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation.

Authors:  Adam J Booth; Ryan Hadley; Ashley M Cornett; Alyssa A Dreffs; Stephanie A Matthes; Jessica L Tsui; Kevin Weiss; Jeffrey C Horowitz; Vincent F Fiore; Thomas H Barker; Bethany B Moore; Fernando J Martinez; Laura E Niklason; Eric S White
Journal:  Am J Respir Crit Care Med       Date:  2012-08-30       Impact factor: 21.405

Review 6.  Roles of Periostin in Respiratory Disorders.

Authors:  Kenji Izuhara; Simon J Conway; Bethany B Moore; Hisako Matsumoto; Cecile T J Holweg; John G Matthews; Joseph R Arron
Journal:  Am J Respir Crit Care Med       Date:  2016-05-01       Impact factor: 21.405

7.  Following the path of CCL2 from prostaglandins to periostin in lung fibrosis.

Authors:  Bethany B Moore
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

Review 8.  Molecular biomarkers in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Kevin K Brown; Harold R Collard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-26       Impact factor: 5.464

Review 9.  Matrix biomechanics and dynamics in pulmonary fibrosis.

Authors:  Andrew J Haak; Qi Tan; Daniel J Tschumperlin
Journal:  Matrix Biol       Date:  2017-12-21       Impact factor: 11.583

10.  Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model.

Authors:  Lynne A Murray; Huilan Zhang; Sameer R Oak; Ana Lucia Coelho; Athula Herath; Kevin R Flaherty; Joyce Lee; Matt Bell; Darryl A Knight; Fernando J Martinez; Matthew A Sleeman; Erica L Herzog; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.